-
1
-
-
0027173231
-
Estimates of the worldwide incidence of eighteen major cancers in 1985
-
Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 1993; 54: 594-606.
-
(1993)
Int J Cancer
, vol.54
, pp. 594-606
-
-
Parkin, D.M.1
Pisani, P.2
Ferlay, J.3
-
2
-
-
0025104871
-
Trends and differentials in ovarian cancer: Incidence, mortality and survival experience
-
Hanai A. Trends and differentials in ovarian cancer: incidence, mortality and survival experience. APMIS Suppl 1990; 12: 1-20.
-
(1990)
APMIS Suppl
, vol.12
, pp. 1-20
-
-
Hanai, A.1
-
3
-
-
0030914791
-
Trends in the incidence of ovarian cancer and borderline tumours in Norway, 1954-93
-
Bjørge T, Engeland A, Hansen S, Tropé CG. Trends in the incidence of ovarian cancer and borderline tumours in Norway, 1954-93. Int J Cancer 1997; 71: 780-6.
-
(1997)
Int J Cancer
, vol.71
, pp. 780-786
-
-
Bjørge, T.1
Engeland, A.2
Hansen, S.3
Tropé, C.G.4
-
5
-
-
0032473544
-
Prognosis of patients with ovarian cancer and borderline tumours diagnosed in Norway between 1954 and 1993
-
Bjørge T, Engeland A, Hansen S, Tropé CG. Prognosis of patients with ovarian cancer and borderline tumours diagnosed in Norway between 1954 and 1993. Int J Cancer 1998; 75: 663-70.
-
(1998)
Int J Cancer
, vol.75
, pp. 663-670
-
-
Bjørge, T.1
Engeland, A.2
Hansen, S.3
Tropé, C.G.4
-
6
-
-
0031026893
-
Epithelial ovarian carcinoma
-
Kristensen GB, Tropé C. Epithelial ovarian carcinoma. Lancet 1997; 349: 113-17.
-
(1997)
Lancet
, vol.349
, pp. 113-117
-
-
Kristensen, G.B.1
Tropé, C.2
-
11
-
-
0026079754
-
Improved prognosis of ovarian cancer in the Netherlands during the period 1975-1985: A registry-based study
-
Balvert-Locht HR, Coebergh JW, Hop WC, Brolmann HA, Crommelin M, van Wijck DJ et al. Improved prognosis of ovarian cancer in The Netherlands during the period 1975-1985: a registry-based study. Gynecol Oncol 1991; 42: 3-8.
-
(1991)
Gynecol Oncol
, vol.42
, pp. 3-8
-
-
Balvert-Locht, H.R.1
Coebergh, J.W.2
Hop, W.C.3
Brolmann, H.A.4
Crommelin, M.5
Van Wijck, D.J.6
-
12
-
-
0027231507
-
Epidemiologic pathology of ovarian cancer from the Vaud Cancer Registry, Switzerland
-
Levi F, Franceschi S, La Vecchia C, Ruzicka J, Gloor E, Randimbison L. Epidemiologic pathology of ovarian cancer from the Vaud Cancer Registry, Switzerland. Ann Oncol 1993; 4: 289-94.
-
(1993)
Ann Oncol
, vol.4
, pp. 289-294
-
-
Levi, F.1
Franceschi, S.2
La Vecchia, C.3
Ruzicka, J.4
Gloor, E.5
Randimbison, L.6
-
13
-
-
0021868905
-
The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer
-
Feinstein AR, Sosin DM, Wells CK. The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med 1985; 312: 1604-8.
-
(1985)
N Engl J Med
, vol.312
, pp. 1604-1608
-
-
Feinstein, A.R.1
Sosin, D.M.2
Wells, C.K.3
-
14
-
-
0016586897
-
Surgical resection of tumor bulk in the primary treatment of ovarian cancer
-
Griffiths CTH. Surgical resection of tumor bulk in the primary treatment of ovarian cancer. Natl Cancer Inst Monogr 1975; 42: 101-4.
-
(1975)
Natl Cancer Inst Monogr
, vol.42
, pp. 101-104
-
-
Griffiths, C.T.H.1
-
15
-
-
0029050211
-
A meta-analysis of residual disease and survival in stage III and IV carcinoma of the ovary
-
Allen DG, Heintz AP, Touw FW. A meta-analysis of residual disease and survival in stage III and IV carcinoma of the ovary. Eur J Gynaecol Oncol 1995; 16: 349-56.
-
(1995)
Eur J Gynaecol Oncol
, vol.16
, pp. 349-356
-
-
Allen, D.G.1
Heintz, A.P.2
Touw, F.W.3
-
16
-
-
0018239343
-
Advanced ovarian adenocarcinoma. A prospective clinical trial of melphalan (L-PAM) versus combination chemotherapy
-
Young RC, Chabner BA, Hubbard SP. Fisher RI, Bender RA, Anderson T et al. Advanced ovarian adenocarcinoma. A prospective clinical trial of melphalan (L-PAM) versus combination chemotherapy. N Engl J Med 1978; 299: 1261-6.
-
(1978)
N Engl J Med
, vol.299
, pp. 1261-1266
-
-
Young, R.C.1
Chabner, B.A.2
Hubbard, S.P.3
Fisher, R.I.4
Bender, R.A.5
Anderson, T.6
-
17
-
-
0018578301
-
Cis-Dichlorodiammineplatinum(II) for the treatment of advanced ovarian cancer
-
Young RC, Von Hoff DD, Gormley P, Makuch R, Cassidy J, Howser D et al. Cis-Dichlorodiammineplatinum(II) for the treatment of advanced ovarian cancer. Cancer Treat Rep 1979; 63: 1539-44.
-
(1979)
Cancer Treat Rep
, vol.63
, pp. 1539-1544
-
-
Young, R.C.1
Von Hoff, D.D.2
Gormley, P.3
Makuch, R.4
Cassidy, J.5
Howser, D.6
-
18
-
-
0019788593
-
Use of high dose cis-dichlorodiammineplatinum (II) (NSC-119875) following failure on previous chemotherapy for advanced carcinoma of the ovary
-
Barker GJ, Wiltshaw E. Use of high dose cis-dichlorodiammineplatinum (II) (NSC-119875) following failure on previous chemotherapy for advanced carcinoma of the ovary. Br J Obstet Gynaecol 1981; 88: 1192-6.
-
(1981)
Br J Obstet Gynaecol
, vol.88
, pp. 1192-1196
-
-
Barker, G.J.1
Wiltshaw, E.2
-
19
-
-
0030054309
-
Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer
-
McGuire WP, Hoskins WJ, Brady MF, Kucera PR, Partridge EE, Look KY et al. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. N Engl J Med 1996; 334: 1-6.
-
(1996)
N Engl J Med
, vol.334
, pp. 1-6
-
-
McGuire, W.P.1
Hoskins, W.J.2
Brady, M.F.3
Kucera, P.R.4
Partridge, E.E.5
Look, K.Y.6
|